Palisade Share Price
NASDAQ: PALI | Micro Cap | HealthcarePalisade Stock Performance
Palisade Share Price Today
As of 19 November 2026, Palisade Bio, Inc.'s share price is $0.96. The stock opened at $1.00, compared to its previous close of $1.01. During today's trading session, Palisade Bio, Inc.'s share price traded between $0.94 and $1.00, with an average price of $0.97. Over the past 52 weeks, the stock has recorded a high of $2.85 and a low of $0.94. In terms of performance, Palisade Bio, Inc.'s share price has declined by 54.84% over the last six months and is down 54.30% on a year-on-year basis.
Palisade Share Price Chart
Palisade Quarterly Profit & Loss
All figures in USD
Palisade Annual Profit & Loss
All figures in USD
Palisade Balance Sheet
All figures in USD Million
Palisade Cash Flow
All figures in USD Million
Corporate Actions
About Palisade
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.
Palisade Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Nov 2026 | $1.19 | $0.96 | -17.86% |
Oct 2026 | $1.37 | $1.17 | -12.36% |
Sep 2026 | $1.98 | $1.33 | -36.73% |
Aug 2026 | $1.90 | $2.11 | +11.35% |
Jul 2026 | $2.13 | $1.90 | -10.19% |
Jun 2026 | $2.12 | $2.11 | -0.94% |
May 2026 | $1.97 | $2.13 | +7.04% |
Apr 2026 | $1.76 | $1.99 | +13.71% |
Mar 2026 | $1.75 | $1.75 | -1.41% |
Feb 2026 | $1.49 | $1.77 | +18.33% |
Jan 2026 | $2.40 | $1.50 | -36.44% |
Dec 2025 | $2.03 | $2.36 | +12.11% |